Chronic venous insufficiency and varicose veins in young people
Authors:
F. Kováčik; A. Smékal; J. Přeček; O. Moravec; M. Hutyra; P. Heinc; M. Táborský
Authors place of work:
I. interní klinika – kardiologická LF UP a FN Olomouc
Published in the journal:
Kardiol Rev Int Med 2018, 20(2): 109-111
Summary
Varicose veins of the lower limbs belong to civilization diseases with typical symptoms. The cause is the rise of venous pressure as a result of valvular reflux or obstruction. The diagnosis is based on medical history, morphological and functional examinations. The treatment is conservative, sclerotherapy and endovascular sclerotherapy, or surgical treatment.
Key words:
chronic venous disease – varicose veins of the lower limbs – venoactive drugs
Zdroje
1. Yao JS. Varicose Veins. Asian J Surg 2003; 26(2): 59– 61. doi: 10.1016/ S1015-9584(09)60221-9.
2. Arnoldi CC. The aetiology of primary varicose veins. Dan Med Bull 1957; 4(3): 102– 107.
3. Dodd H, Cockett FB. The pathology and surgery of the veins of the lower limbs. Edinburgh: E & S Livingston 1956.
4. Beebe-Dimmer JL, Pfeifer JR, Engle JS et al. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005; 15(3): 175– 184. doi: 10.1016/ j.annepidem.2004.05.015.
5. Musil D. Varixy a chronická žilní nedostatečnost. Med Pro Praxi 2001; 3(11): 526– 530.
6. Fowkes FG, Lee AJ, Evans CJ et al. Lifestyle risk factors for lower limb venous reflux in the general population: Edinburgh Vein Study. Int J Epidemiol 2001; 30(4): 846– 852.
7. Laurikka JO, Sisto T, Tarkka MR et al. Risk indicators for varicose veins in fortyto sixty-year-olds in the Tampere varicose vein study. World J Surg 2002; 26(6): 648– 651. doi: 10.1007/ s00268-001-0283-1.
8. Boisseau MR. Chronic venous disease and the genetic influence. Phlebolymphology 2013; 21(2): 100– 109.
9. Herman J. Varixy dolních končetin – diagnostika, léčba, recidiva. Med Pro Praxi 2010; 7(11): 420– 422.
10. Classification and grading of chronic venous disease in the lower limbs: a consensus statement. Phlebology 1995; 10: 42– 45. Available at: http:/ / journals.sagepub.com/ doi/ pdf/ 10.1177/ 026835559501000202.
11. Karetová D, Chochola M a kol. Vaskulární medicína. Praha: Maxdorf 2017.
12. Muchová I. Kompresivní terapie v angiologii. Doporučený postup České angiologické společnosti ČLS JEP 2017. Dostupné na: http:/ / wp.interna-cz.eu/ guidelines/ angiologie.
13. Karetová D. Farmakologická léčba chronické žilní insuficience. Doporučené postupy České angiologické společnosti ČLS JEP 2017. Dostupné z: http:/ / wp.interna-cz.eu/ guidelines/ angiologie.
14. Jungbeck C, Jungbeck C, Peterson K et al. A randomised controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease. Eur J Vasc Endovasc Surg 2002; 23(1): 73– 76. doi: 10.1053/ ejvs.2001.1531.
15. Nicolaides A, Kakkos S, Eklof B et al. Management of chronic venous disorders of the lower limbs – guidelines according to scientific evidence. Int Angiol 2014; 33(2): 87– 208.
16. Antignani PL. Medical treatment of chronic venous disease. SM J Pharmac Ther 2017; 3(1): 1015.
17. Slonková V. Nová klasifikace venoaktivních léků. Dermatol praxi 2016; 10(4): 178– 180.
18. Musil D. Moderní léčba chronického žilního onemocnění. Dermatol praxi 2013; 7(1): 21– 25.
19. Gloviczki P, Gloviczki ML. Guidelines for the management of varicose veins. Phlebology 2012; 27 (Suppl 1): 2– 9. doi: 10.1258/ phleb.2012.012S28.
Štítky
Paediatric cardiology Internal medicine Cardiac surgery CardiologyČlánok vyšiel v časopise
Cardiology Review
2018 Číslo 2
Najčítanejšie v tomto čísle
- Arrhythmias in young adults
- Juvenile hypertension
- Fixed dose combination of rosuvastatin and ezetimibe – drug profile
- Chronic venous insufficiency and varicose veins in young people